首页> 外文会议>Πανελληνιο Συνεδριο ΤροΦιμων >IN VITRO AND IN VIVO STUDY OF GASTROINTESTINAL SURVIVAL OF LACTOBACILLUS CASEI ATCC 393, ADHESION TO INTESTINAL MUCOSA AND MODULATION OF INTESTINAL MICROBIAL FLORA
【24h】

IN VITRO AND IN VIVO STUDY OF GASTROINTESTINAL SURVIVAL OF LACTOBACILLUS CASEI ATCC 393, ADHESION TO INTESTINAL MUCOSA AND MODULATION OF INTESTINAL MICROBIAL FLORA

机译:体外和体内研究Lactobacillus酪蛋白ATCC 393的胃肠道存活,对肠粘膜的粘附和肠道微生物菌群的调节

获取原文

摘要

Nowadays an upsurge of interest in developing novel foods containing probiotic microorganisms, such as lactic acid bacteria, is observed. Such functional foods have a great potential in promoting human health. In order to deliver the health benefits, probiotics need to contain an adequate amount of live bacteria (at least 10~6 cfu/g), able to survive the acidic conditions of the upper gastrointestinal (GI) tract and proliferate in the intestine, a requirement that is not always fulfilled. Since it is well established that cell immobilization enhances the viability of cultures, the aim of the present study was to assess (a) the in vitro and in vivo Gl survival of both free and immobilized L. casei ATCC 393 on apple pieces contained in probiotic fermented milk, (b) the in vivo adhesion to the intestinal mucosa, and (c) potential regulation of intestinal microbial flora in a rat model. In in vitro GI stress tolerance tests, immobilized L casei ATCC 393 exhibited significantly higher survival rates compared to free cells. At a second stage, probiotic fermented milk produced by either free or immobilized cells was administered orally at a single dose or daily in Wistar rats. By 12 h after single dose administration, both free and immobilized cells were detected by microbiological and molecular analysis at levels ≥ 10~6 cfu/g of feces. Moreover, in vivo adhesion of L. casei ATCC 393 at the rat GI tract was detected. Specifically, the adhesion of the probiotic cells at the large intestine (cecum and colon) was recorded at levels ≥ 10~6 cfu/g (suggested minimum levels for conferring a probiotic effect) following daily administration for 7 days. Their levels were lower at the small intestine (duodenum, jejunum and ileum) (≤ 10~3 cfu/g), indicating that adhesion was a targeted process. The colonization of the GI tract detected by multiplex PCR was transient. Thus, daily consumption of probiotic products containing the specific strain appears to be a prerequisite for retaining its levels at an effective concentration, information that could be valuable for the food industry. Finally, daily administration of the probiotic products led to significant reduction of staphylococci, enterobacteria, coliforms and streptococci counts in rat feces. In conclusion, L. casei ATCC 393 contained in fermented milk survived GI transit, adhered to the intestinal mucosa and modulated intestinal microbiota.
机译:如今,观察到对含有益生菌微生物(例如乳酸菌)的新型食物的兴趣增加了兴趣。这种功能性食品在促进人类健康方面具有巨大潜力。为了提供健康益处,益生菌需要含有足够量的活细菌(至少10〜6 CFU / g),能够在上胃肠道(GI)道的酸性条件下并在肠道中增殖未始终满足的要求。由于众所周知,细胞固定化增强培养物的活力,本研究的目的是评估(a)在益生菌中含有的苹果片上的自由和固定的L.酪虫ATCC 393的体外和体外生存期发酵牛奶,(b)对肠粘膜的体内粘附,(c)大鼠模型中肠道微生物菌群的潜在调节。在体外GI胁迫性耐受性试验中,与游离细胞相比,固定的L表壳ATCC 393表现出显着更高的存活率。在第二阶段,通过自由或固定细胞产生的益生菌发酵乳在单剂量或每天在Wistar大鼠中口服给药。在单剂量给药后12小时,通过微生物和分子分析在≥10〜6 cfu / g型粪便中进行微生物和分子分析来检测自由和固定细胞。另外,检测到大鼠Gi池的L.SieSi ATCC 393的体内粘附。具体地,在每日施用7天后,在每日施用后,记录在大肠(盲肠和结肠)在大肠(盲肠和结肠)处的益生菌细胞的粘附性≥10〜6 cfu / g(建议赋予益生菌效应的最小水平)。它们的水平在小肠(十二指肠,Jejunum和Hileum)(≤10〜3 cfu / g)下降,表明粘附是靶向过程。通过多重PCR检测到的GI沟的定植是瞬时的。因此,含有特定菌株的益生菌产品的日常消费似乎是以有效浓度保持其水平的先决条件,这可能对食品行业有价值的信息。最后,每日施用益生菌产品导致葡萄球菌,细菌,大肠菌菌,大鼠粪便中的链球菌的显着降低。总之,发酵牛奶中含有的酪蛋白ATCC 393存活的GI转运,粘附在肠粘膜和调节的肠道微生物酵母中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号